154 related articles for article (PubMed ID: 38273370)
1. Validation of the psychosocial consequences of screening in lung cancer questionnaire in the international lung screen trial Australian cohort.
Bonney A; Brodersen J; Siersma V; See K; Marshall HM; Steinfort D; Irving L; Lin L; Li J; Pang S; Fogarty P; Brims F; McWilliams A; Stone E; Lam S; Fong KM; Manser R
Health Qual Life Outcomes; 2024 Jan; 22(1):10. PubMed ID: 38273370
[TBL] [Abstract][Full Text] [Related]
2. Consequences of screening in cervical cancer: development and dimensionality of a questionnaire.
Brodersen J; Siersma V; Thorsen H
BMC Psychol; 2018 Aug; 6(1):39. PubMed ID: 30097013
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial consequences of false positives in the Danish Lung Cancer CT Screening Trial: a nested matched cohort study.
Rasmussen JF; Siersma V; Malmqvist J; Brodersen J
BMJ Open; 2020 Jun; 10(6):e034682. PubMed ID: 32503869
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST).
Rasmussen JF; Siersma V; Pedersen JH; Brodersen J
Lung Cancer; 2015 Jan; 87(1):65-72. PubMed ID: 25433982
[TBL] [Abstract][Full Text] [Related]
5. Consequences of screening in colorectal cancer (COS-CRC): development and dimensionality of a questionnaire.
Malmqvist J; Siersma V; Bang CW; Brodersen J
BMC Psychol; 2021 Jan; 9(1):7. PubMed ID: 33413695
[TBL] [Abstract][Full Text] [Related]
6. Consequences of screening in lung cancer: development and dimensionality of a questionnaire.
Brodersen J; Thorsen H; Kreiner S
Value Health; 2010 Aug; 13(5):601-12. PubMed ID: 20345552
[TBL] [Abstract][Full Text] [Related]
7. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
[TBL] [Abstract][Full Text] [Related]
8. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S
Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336
[TBL] [Abstract][Full Text] [Related]
9. Adaptation to Swedish and further development of the 'Consequences of Screening - Breast Cancer' questionnaire: a multimethod study.
Bolejko A; Wann-Hansson C; Zackrisson S; Brodersen J; Hagell P
Scand J Caring Sci; 2013 Jun; 27(2):475-86. PubMed ID: 22804720
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial consequences of a three-month follow-up after receiving an abnormal lung cancer CT-screening result: A longitudinal survey.
Damhus CS; Quentin JG; Malmqvist J; Siersma V; Brodersen J
Lung Cancer; 2021 May; 155():46-52. PubMed ID: 33725548
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial.
Aggestrup LM; Hestbech MS; Siersma V; Pedersen JH; Brodersen J
BMJ Open; 2012; 2(2):e000663. PubMed ID: 22382119
[TBL] [Abstract][Full Text] [Related]
13. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
14. Did psychosocial status, sociodemographics and smoking status affect non-attendance in control participants in the Danish Lung Cancer Screening Trial? A nested observational study.
Malmqvist J; Siersma V; Thorsen H; Heleno B; Rasmussen JF; Brodersen J
BMJ Open; 2020 Feb; 10(2):e030871. PubMed ID: 32086352
[TBL] [Abstract][Full Text] [Related]
15. Development and Psychometric Evaluation of the Lung Cancer Screening Health Belief Scales.
Carter-Harris L; Slaven JE; Monohan P; Rawl SM
Cancer Nurs; 2017; 40(3):237-244. PubMed ID: 27244666
[TBL] [Abstract][Full Text] [Related]
16. Protocol and Rationale for the International Lung Screening Trial.
Lim KP; Marshall H; Tammemägi M; Brims F; McWilliams A; Stone E; Manser R; Canfell K; Weber M; Connelly L; Bowman RV; Yang IA; Fogarty P; Mayo J; Yee J; Myers R; Atkar-Khattra S; Lam DCL; Rosell A; Berg CD; Fong KM; Lam S;
Ann Am Thorac Soc; 2020 Apr; 17(4):503-512. PubMed ID: 32011914
[No Abstract] [Full Text] [Related]
17. Adaptation and validation of the Chinese version of the lung cancer screening health belief scales.
Lin YA; Carter-Harris L; Yang JN; Lin XJ; Huang FF
BMC Public Health; 2022 Mar; 22(1):620. PubMed ID: 35354440
[TBL] [Abstract][Full Text] [Related]
18. Translation and psychometric properties of the King's Sarcoidosis Questionnaire (KSQ) in German language.
Farin E; Heyduck K; Frye BC; Birring SS; Müller-Quernheim J; Schupp JC
Health Qual Life Outcomes; 2019 Apr; 17(1):62. PubMed ID: 30975148
[TBL] [Abstract][Full Text] [Related]
19. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
[TBL] [Abstract][Full Text] [Related]
20. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
